Ischemic Postconditioning Mitigates Lipopolysaccharide-induced Acute Lung Injury in Rats.

Area of Science:

• Pulmonary Medicine
• Cardiovascular Research
• Cellular Biology

Background:

• Acute lung injury (ALI) is a critical condition with high mortality, characterized by lung barrier disruption, inflammation, and edema.
• Current treatments for ALI are limited, highlighting the need for novel therapeutic approaches.
• Lipopolysaccharide (LPS) is a common inducer of experimental ALI, mimicking key pathological features.

Purpose of the Study:

• To investigate the therapeutic potential of remote ischemic postconditioning (RIPostC) in LPS-induced ALI.
• To explore the underlying mechanisms, focusing on inflammatory and apoptotic pathways.

Main Methods:

• ALI was induced in rats via intraperitoneal LPS injection.
• RIPostC involved cycles of ischemia and reperfusion in the hind limbs.
• Inflammation and apoptosis were quantified using ELISA and TUNEL staining; histopathology was assessed via H&E staining.

Main Results:

• LPS administration led to significant neutrophil infiltration and apoptosis in lung tissue.
• RIPostC treatment successfully prevented these LPS-induced pathological changes.
• Serum transfer experiments indicated that protective factors could be mediated systemically.

Conclusions:

• RIPostC demonstrates significant ameliorative effects on LPS-induced ALI in a rat model.
• The protective mechanism of RIPostC involves the suppression of apoptosis and neutrophil infiltration in the lungs.
• RIPostC represents a promising, non-invasive therapeutic strategy for ALI.